Precision BioSciences Inc (DTIL) verðbréfaverð og fréttir

HeimDTIL • NASDAQ

Precision BioSciences Inc

3,97 $

21. jan., 13:36:32 GMT-5 · USD · NASDAQ · Lagalegir fyrirvarar

Við síðustu lokun

4,17 $

Dagbil

3,90 $ - 4,17 $

Árabil

3,75 $ - 8,82 $

Markaðsvirði

90,90 m. USD

Meðalmagn

244,04 þ.

V/H-hlutf.

A/V-hlutfall

Aðalkauphöll

NASDAQ

Viðskiptafréttir

MarketBeat

fyrir 17 mínútum

Simmons First National (NASDAQ:SFNC) Trading 7.1% Higher After Strong Earnings

Dow Jones Today: DJIA Gains as Trump Rules Out Using Force Against Greenland; Global Leaders Converge for WEF

“Natural-Language Commands into Control Signals…” Microsoft Stock (NASDAQ:MSFT)

Yahoo Finance

fyrir 5 klukkustundum

Stock market today: Dow, S&P 500, Nasdaq futures slip after brutal sell-off in wait for Trump's Davos speech

Trump in Davos says NATO should allow the US to take Greenland but he won’t use force

Fortune

fyrir 4 klukkustundum

The NYSE's big tokenization plan is nothing but vaporware a says Columbia business professor

Precision BioSciences, Inc. is a publicly traded American clinical stage gene editing company headquartered in Durham, North Carolina. Founded in 2006, Precision is focused on developing both in vivo and ex vivo gene editing therapies using its proprietary "ARCUS" genome editing platform. Wikipedia

Stofnsett

2006

Vefsvæði

precisionbiosciences.com

Starfsfólk